Fycompa in Subjects With Small Fiber Neuropathy (SFN)

Summary

This is a Phase II, 2 arm randomized crossover study. Subjects will be assigned to either active agent or placebo and then crossover to the other arm. This study is designed to evaluate whether Fycompa improves the quality of life in patients with small fiber neuropathy.

Timeline

Start

2016-01

Primary completion

2016-12

Completion

2016-12

Drugs

Indications